Codiak BioSciences, Inc. Operating Lease Liability
Codiak BioSciences, Inc. had Operating Lease Liability of $35.58 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-11-03
- 2022-09-30: Operating Lease, Liability $35.58M.
- 2022-06-30: Operating Lease, Liability $36.25M.
- 2022-03-31: Operating Lease, Liability $36.91M.
- 2021-12-31: Operating Lease, Liability $37.55M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-09-30 | $35.58M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $36.25M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $36.91M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $37.55M 10-K · filed 2022-03-10 |
| 2021-09-30 | $37.10M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $37.64M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $38.16M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $38.02M 10-K · filed 2021-03-17 |
| 2020-09-30 | $38.88M 10-Q · filed 2020-11-19 |